BIOLASE to Present at the LD Micro Summit

IRVINE, CA -- (Marketwire) -- 09/28/12 -- BIOLASE, Inc. (NASDAQ: BIOL), the World's leading biological dental laser manufacturer and distributor, today announced that Frederick Furry, Chief Operating Officer and Chief Financial Officer, will make an investor presentation at the LD Micro Summit on Thursday, October 4, 2012, at 1 PM Pacific Time. The conference is being held at the Luxe Sunset Bel Air Hotel in Los Angeles.

The presentation will also be accessible by live webcast under the "Investors" section of BIOLASE's website at www.biolase.com and remain available for two weeks after the actual presentation date.

About BIOLASE, Inc.
BIOLASE, Inc., the World's leading Dental Laser Company, is a medical technology company that develops, manufactures and markets biological dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate approximately 290 patented and patent pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 20,100 lasers among 16,000 customers. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on the Waterlase and laser dentistry, find BIOLASE online at http://www.biolase.com, Facebook at https://www.facebook.com/biolaseinc, Twitter at https://twitter.com/biolaseinc, and YouTube at https://www.youtube.com/biolasevideos.

For further information, please contact
Lisa Wilson
In-Site Communications, Inc.
212-759-3929

Source: BIOLASE, Inc.

Released September 28, 2012